Moderna and Pfizer-BioNTech ask FDA to authorize omicron boosters for children

Published



Vaccine manufacturers Pfizer-BioNTech and Moderna have asked the U.S. Food and Drug Administration to authorize their omicron-specific COVID-19 booster candidates for school-aged children.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.